We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

Pharmacy group Dis-Chem says its recent string of acquisitions helped its revenue exceed R30bn for the first time in its history in its 2022 financial year, and it is optimistic about both a normalisation of shopping habits and better-than-expected uptake of its new health insurance offerings.

Dis-Chem’s health and personal care focus means it remains in the resilient part of the consumer retail market, CFO Rui Morais told Business Day, and the group is encouraged by returning footfall at larger malls, which consumers had avoided during the pandemic...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now